Thaddeus (Thad) Davis

Thaddeus (Thad) Davis

Adjunct Professor
Global Doctor of Business Administration




Thaddeus (“Thad”) Davis has specialized in healthcare for over two decades as both an operator and financial advisor. His experience encompasses all healthcare sub-sectors including pharmaceuticals, devices, life sciences, services, digital health, and managed care.  As an advisor, Thad has evaluated over 350 potential transactions and has executed on over 100 of those opportunities since 2010. As an operator, Thad has led process, technology and strategy initiatives across both clinical and operational functions.

Thad is currently a Senior Managing Director at SVB Securities.  Thad is responsible for the leadership of leveraged finance at SVB Securities with a secondary focus on healthcare sector coverage.  Thad is a key member of the senior leadership team, spanning SVB and SVB Securities, driving the expansion of the firm’s existing leveraged finance capabilities.

Previously, Thad was the Head of Healthcare Investment Banking for the Americas at HSBC. Thad was responsible for the successful re-launch HSBC’s Healthcare Investment Banking practice in the Americas.  Thad was directly responsible for the P&L of the practice including origination, relationship oversight, team leadership, and transaction execution. Thad established HSBC as relevant to healthcare-focused private equity sponsors through a content-driven strategy, expanded HSBC’s relationships with both healthcare and non-healthcare financial sponsors, and established the inaugural investment banking coverage of HSBC’s corporate clients.

Prior to joining HSBC, Thad was with the global healthcare investment banking team both at Jefferies and UBS. 

Before his time in investment banking, Thad was a Manager of Strategy with Caremark where he led strategic initiatives within the prescription benefit, specialty pharmacy, and disease management lines of business. Examples of Thad’s work at Caremark include the launch of and the design and implementation of the world’s first cross-class, cross-therapeutic drug database.

Earlier in his career, Thad was a strategy and technology consultant with several leading advisory firms.  Thad’s work included strategy engagements, process re-engineering, enterprise software development, and program management.  Thad’s work has been noted in Harvard Business Review Case Studies and by Jim Collins in his book Good to Great.

Thad holds a Bachelor of Science in Management from Purdue University and an MBA from the University of Chicago Booth School of Business. Thad is an adjunct professor at the University of Minnesota and the University of Maryland.  Also, Thad is on the executive committee of the board of directors at the New York Common Pantry. 

Edit This Page

Edit Profile